• Home
  • Technology
  • Gaming
  • Entertainment
  • World & Business
  • Science
  • Sports
  • AI
HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
    • Home
    • Technology
    • Gaming
    • Entertainment
    • World & Business
    • Science
    • Sports
    • AI
    AI
    Reaction

    The gap between AI breakthroughs and public benefits could fuel backlash

    One poster argues that companies could reap windfalls from fusion or cancer breakthroughs long before the public benefits.

    Lisan al GaibLA
    1 Source, 33m ago, first seen 33m ago

    TLDR

    A user predicts that anti-AI sentiment will rise over the next few years even without AI-driven unemployment. They argue that companies could see immediate financial gains from breakthroughs while benefits for the public take years to arrive. They expect pushback through regulation or taxation and suggest equity-based dividends for citizens, alongside AI innovations that pay off for people sooner.

    Combined views

    1K

    1 Source, first seen 33m ago

    Combined views

    1K

    1 Source, first seen 33m ago

    15 likes
    15 likes
    5 comments
    3 saves
    1 reposts
    5 comments
    3 saves
    1 reposts
    Featured Source

    Sentiment

    Positive——Negative

    Summary

    Not enough discussion yet.

    No sentiment analysis available yet.

    Sentiment

    Positive——Negative

    Summary

    Not enough discussion yet.

    No sentiment analysis available yet.

    Today's Rank

    #5

    Today's Rank

    #5

    1 Source

    Lisan al Gaib@scaling01I find it hard to believe that any scientific breakthrough could prevent everyday people from turning more anti-AI over the next few years. And I don't think this depends on AI pushing up unemployment. I think it depends on the gap between when breakthroughs pay off for companies and everyone else. For example, a fusion or cancer breakthrough probably wouldn't improve the average american's life within the next five years, as infrastructure takes time to build and drugs have to go through trials. But the AI lab and partner companies that made the discovery would feel it immediately, in their market caps and in massive windfalls. Something similar already happens with pharma. People hate pharma companies, but still use their products. The same will probably happen to AI companies, except it will happen across many industries at once. This will take shape in the next presidential elections. The more successful AI companies become, the more pushback they'll get, in the form of regulation or taxation. And I don't think AI companies should really resist that. They will just make themselves more unlikeable. Both USG and labs should push hard on distributing the benefits, through something like equity based dividends for every citizen. Labs should also prioritize innovations that pay off for people quickly, and ones that shrink the pay-off gap.1h

    1 Source

    Lisan al Gaib@scaling01I find it hard to believe that any scientific breakthrough could prevent everyday people from turning more anti-AI over the next few years. And I don't think this depends on AI pushing up unemployment. I think it depends on the gap between when breakthroughs pay off for companies and everyone else. For example, a fusion or cancer breakthrough probably wouldn't improve the average american's life within the next five years, as infrastructure takes time to build and drugs have to go through trials. But the AI lab and partner companies that made the discovery would feel it immediately, in their market caps and in massive windfalls. Something similar already happens with pharma. People hate pharma companies, but still use their products. The same will probably happen to AI companies, except it will happen across many industries at once. This will take shape in the next presidential elections. The more successful AI companies become, the more pushback they'll get, in the form of regulation or taxation. And I don't think AI companies should really resist that. They will just make themselves more unlikeable. Both USG and labs should push hard on distributing the benefits, through something like equity based dividends for every citizen. Labs should also prioritize innovations that pay off for people quickly, and ones that shrink the pay-off gap.1h